OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Dermatology is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
银屑病皮肤细胞中的小分子 RNA 促进炎症发生	231
Correction	180
P91: Cutaneous adverse events of immune check point inhibitors nivolumab, pembrolizumab and atezolizumab: a multicentric study	146
Adding up the desmosomal genes causing syndromes with hair and skin involvement: identification of TUFT1 by state-of-the-art whole-genome sequencing	122
Atypical melanocytes of an atypical Spitz tumour observed with optical super-high magnification dermoscopy	107
How to score the impact of treatment on cutaneous neurofibromas in clinical trials	96
The association of anxiety with granuloma annulare: a case–control study of the National Institutes of Health ‘All of Us’ research programme	88
Delusional infestation – do not be scared!	87
O11 The human discs large protein (Dlg1) controls connexin 43 (Cx43) plasma membrane localization and gap junctional communication in keratinocytes	82
O06 Exploring host–microbiome–immune interactions using singular and multispecies inoculations in optimized 3D skin models	77
Interactive effect of genetic and environmental risk factors on psoriasis: current evidence and future directives	76
Editor's Choice – John Ingram – Sep 2023	76
一项在一家大型教学医院进行的 5 年皮肤附属器肿瘤研究, 对关联基因诊断提供了启示	71
对化疗所致脱发的更深入了解	70
P100: Efficacy of current treatments under study in patients with alopecia areata	69
BH13: Scarring alopecia affecting a congenital melanocytic naevus in a patient with frontal fibrosing alopecia	66
P15: Twenty years of the UK Dermatology Clinical Trials Network: past, present and future	64
CPC11: Bromoderma in a patient with chronic obstructive pulmonary disease	62
P57: New order: redesigning referral pathways to improve access for patients from dermatology outpatient waiting lists	60
H10: A Sweet diagnosis to make: the history of Robert Douglas Sweet and acute febrile neutrophilic dermatosis	59
开展健康宣传活动，禁售日光浴床，以减少皮肤癌: 合理利用医疗预算	59
P52: Opportunities for implementing a patient‐initiated follow‐up pathway in patients with psoriasis completing narrowband ultraviolet B phototherapy	58
BH09: Frontal fibrosing alopecia in men: is it any different?	58
Issue Information	58
DP27: Maculopapular cutaneous mastocytosis mimicking seborrhoeic folliculitis	57

Possible new oral treatment for hidradenitis suppurativa	57
皮肤红斑狼疮治疗指南	55
P53: Office 365: Microsoft Lists as a tool for a secure online second‐line/systemic drug database	55
DP12: An 11‐year mystery	54
Higher proportion of cellulitis in severe lymphoedema	52
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles	50
Greater understanding about differences in the long-term course of eczema and their risk factors in children	49
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin	49
Methotrexate and ciclosporin improve skin biomarkers in paediatric atopic dermatitis: results from the TREatment of severe Atopic eczema Trial	48
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial	48
Occupational skin cancer: measurements of ultraviolet radiation exposure bring knowledge for prevention	46
A current need for the use of improved and standardized outcome measures by clinical studies of pemphigus	46
A guide to using the core outcome set for eczema	45
Editor's Choice – John Ingram – December 2023	45
GD07: The use of the Dermatology Life Quality Index suite of patient‐reported outcome measures in neglected tropical diseases of the skin: a systematic review	45
‘Substantial clinical benefit’ and ‘substantial clinical worsening’ cutoff of Vitiligo Impact Scale (VIS)-22 change scores	44
Risankizumab versus apremilast in the era of skin clearance	44
Corrigendum	43
Mosaic EGFR exon 20 in-frame insertion pathogenic variants are associated with papular epidermal naevus with ‘skyline’ basal cell layer (PENS)	43
BT25: Dermatology and the metaverse: what’s on the horizon?	43